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Summary
CD1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory
activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type
cytokines. We analyzed presentation of NKT cell activating α galactosylceramide (αGalCer) analogs
that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls
the outcome of NKT cell activation. Using a monoclonal antibody specific for αGalCer-CD1d
complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-
biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins.
Complexes formed by association of these Th2 cell-type cytokine-biasing αGalCer analogs with
CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma
membrane microdomains of antigen-presenting cells. These findings help to explain how subtle
alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-
inflammatory activities of NKT cells.
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Introduction
Natural killer T cells (NKT cells) comprise several unconventional T cell subsets that coexpress
T cell antigen receptors (TCRs) and various receptors that are prominently expressed by NK
cells (Godfrey et al., 2004). Among the several subsets of NKT cells, the most well studied are
those that express an invariant TCRα chain, which are known as type 1 or invariant NKT cells
(iNKT cells). These recognize glycolipid antigens presented by the nonpolymorphic MHC
class I-like molecule CD1d (Bendelac et al., 2007). Upon activation, iNKT cells release IFN-
γ and other proinflammatory cytokines, as well as activate a variety of other leukocytes to
express effector functions. Through a combination of these and other activities, iNKT cells can
exert major effects on early and delayed adaptive immunity to tumors and to a wide variety of
infectious pathogens (Crowe et al., 2005; Behar and Porcelli, 2007). In addition, iNKT cells
also contribute to maintenance of immune tolerance (Yu and Porcelli, 2005; Jiang et al.,
2007). This is believed to be related at least in part to the innate programming of iNKT cells
to produce a variety of anti-inflammatory or regulatory cytokines, including high amounts of
several T helper 2 (Th2) cell-associated cytokines such as IL-4, IL-5, and IL-13 (Im et al.,
2006; Sakuishi et al., 2007).
A major advance in iNKT cell research was the discovery of specific glycolipid ligands that
are recognized by these cells when presented by CD1d. The prototypical iNKT cell activator
is a synthetic form of α-galactosylceramide with a C18 phytosphingosine base and a fully
saturated C26 N-linked fatty acyl chain, here referred to as αGalCer-C26:0 (Kawano et al.,
1997). Many studies have shown that αGalCer-C26:0 is a potent activator of both mouse and
human iNKT cells and that it elicits production of both Th1 cell- and Th2 cell-type cytokines.
There has been substantial effort toward identifying activating ligands that can more precisely
focus the outcome of the iNKT cell response, and several studies have shown that alterations
of the basic lipid structure of αGalCer-C26:0 can lead to striking changes in the patterns of
cytokine production (Miyamoto et al., 2001; Schmieg et al., 2003; Goff et al., 2004; Yu et al.,
2005; Fujio et al., 2006). The ability of an iNKT cell-activating ligand to induce a bias toward
production of cytokines associated with Th2 cell responses was first described for the αGalCer
analog designated OCH, in which the sphingoid base was truncated to C9 and the fatty acid
chain was slightly shortened to C24:0 (Miyamoto et al., 2001). A similar cytokine-biasing
property was described by our studies of an αGalCer derivative containing an 11,14-cis-
diunsaturated C20 fatty acid (αGalCer C20:2) (Yu et al., 2005) and by another study of αGalCer
analogs with truncated fatty acyl chains (Goff et al., 2004). Conversely, a few derivatives of
αGalCer have been described that polarize the cytokine response in the opposite direction, with
IFN-γ predominating over IL-4 production (Schmieg et al., 2003; Fujio et al., 2006; Chang
et al., 2007). These compounds are of interest as selective activators of iNKT cell functions,
and such activators may lend themselves to a variety of therapeutic applications (Miyake and
Yamamura, 2005). However, the mechanisms by which structural variants of αGalCer induce
selective activation of iNKT cell functions are not clearly understood, and this imposes limits
on rational development of optimized iNKT cell activators for specific applications.
In the current study, we used a panel of analogs of αGalCer that induced preferential production
of Th2 cell-type cytokines to explore the mechanism by which these compounds induce these
biased cytokine responses. Although these αGalCer analogs showed marked variability in their
avidities for the TCRs of iNKT cells, they consistently displayed the ability to rapidly load
onto CD1d molecules directly at the cell surface of antigen-presenting cells (APCs). This rapid
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loading of CD1d could be directly visualized with a recently developed monoclonal antibody
specific for the complex formed by the binding of αGalCer to murine CD1d. Most notably,
αGalCer-CD1d complexes containing Th2 cell-type cytokine-biasing analogs showed a
marked depletion in their localization to ganglioside-enriched, detergent-resistant
microdomains in the plasma membranes of APCs, providing a mechanistic link between the
structure of CD1d-binding glycolipids and their ability to preferentially induce
immunoregulatory activities of iNKT cells.
Results
Th2 Cell-Type Cytokine-Biasing αGalCer Analogs for Murine iNKT Cells
Eight synthetic αGalCer analogs (Figure 1A) were selected for use in this study from two
synthetic libraries of N-acyl variants of the basic α-galactosyl C18 phytosphingosine structure
(Yu et al., 2005; Li et al., 2007). Among these were two compounds that induce mixed Th1
and Th2 cell-type cytokine responses, αGalCer-26:0 and the closely related αGalCer-C24:0
variant (Forestier et al., 2007). The six analogs that induced predominantly Th2 cell-type
cytokine responses included the previously described OCH and αGalCer-C20:2 and -C20:4
compounds (Miyamoto et al., 2001; Yu et al., 2005) and three additional N-acyl derivatives of
the α-galactosyl C18 phytosphingosine base. These compounds were selected because of their
ability to potently activate mouse iNKT cell hybridomas (Figure 1B and Figure S1 available
online), as well as their induction of increased ratios of IL-13 or IL-4 to IFN-γ from mouse
splenocytes (Figure 1C and Figure S2). In vivo analysis revealed that injection of mice with
five of the six Th2 cell-type cytokine-biasing analogs produced concentrations of circulating
IL-4 that were similar to or greater than those produced by injection of αGalCer-C26:0 and -
C24:0 compounds (Figure 1D), but in all cases these compounds elicited low or undetectable
serum IFN-γ either early (2 hr) or late (23 hr) after injection. As we previously reported
(Forestier et al., 2007), circulating IL-12p70 concentrations in vivo did not correlate with the
Th2 cell-type cytokine-biasing properties of either OCH or αGalCer-C20:2, although other
analogs with a similar bias toward Th2 cell-type cytokine production showed a tendency toward
reduced IL-12p70 production (Figure 1D). One of the analogs studied, αGalCer-4FPA, showed
minimal activity in vivo in C57BL/6 mice (Figure 1D) but was included because of its
pronounced Th2 cell-type biasing effect in vitro. Most of the αGalCer analogs in this panel
were also able to strongly stimulate human iNKT cells in vitro (Figure S3).
Murine and Human iNKT Cell TCR Interactions with αGalCer Analogs
The interactions of iNKT cell TCRs with CD1d molecules loaded with αGalCer analogs were
analyzed with fluorescent murine and human CD1d tetramers. This demonstrated that iNKT
cells recognizing each analog were also strongly reactive with αGalCer-C26:0, although
staining patterns in some cases indicated differences in relative TCR avidities (Figure 2A).
Equilibrium binding studies for measuring TCR avidities were carried out by incubation of
human or murine iNKT cells with varying concentrations of αGalCer-analog-loaded tetramers
and determining relative levels of cell-associated fluorescence (Stanic et al., 2003; Yu et al.,
2005). A wide range of TCR avidities was observed for mouse CD1d (mCD1d) and human
CD1d (hCD1d) complexes formed with different Th2 cell-type cytokine-biasing αGalCer
analogs (Figures 2B and 2C). Notably, complexes loaded with some of these analogs showed
avidities that were equal to or exceeded those of αGalCer-C26:0 or -C24:0 loaded complexes,
arguing that low TCR avidity was not the main or sole determinant responsible for altered
cytokine responses.
APC Requirement and Kinetic Features of Presentation of αGalCer Analogs
A previous study suggested that an iNKT cell response biased toward production of Th2 cell-
type cytokines could result from preferential presentation of αGalCer by B lymphocytes
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(Bezbradica et al., 2005). We studied this possibility directly by using a monoclonal antibody
(L363) that specifically recognizes complexes of αGalCer bound to mCD1d (Yu et al., 2007).
Mouse splenocytes were cultured with either αGalCer-C26:0 or representative Th2 cell-type
cytokine-biasing analogs, and L363 staining was assessed on various cell types (Figure 3A).
This revealed that all αGalCer analogs were presented most prominently on CD11c+ DCs, and
only one of the two analogs that induced a Th2 cell-type cytokine response showed clearly
detectable presentation by B cells even after prolonged incubation (19 hr). However, the
extremely early appearance of L363 staining on cells exposed to αGalCer-C10:0 suggested
that rapid kinetics of presentation might be a key feature of αGalCer analogs that induce a bias
toward Th2 cell-type cytokines. This was investigated further with more detailed kinetic studies
in which immortalized mouse DC line JAWS II was cultured with each glycolipid and assessed
for L363 surface staining at 0.5, 4, and 18 hr (Figure 3B). There was a striking correlation
between rapid kinetics of glycolipid association with mCD1d and the ability to induce a Th2
cell-type cytokine response. For analogs that induced a mixed cytokine response (αGalCer-
C26:0 and -C24:0), strong L363 staining was detected only at 18 hr. In contrast, most analogs
inducing Th2 cell-type cytokine responses gave strong L363 staining by 0.5 hr, which increased
modestly or not at all with longer incubation. The single exception was OCH, which in general
gave very weak L363 reactivity, although this was also apparent by 4 hr. A pulse-chase analysis
revealed that mCD1d-αGalCer surface complexes formed slowly with αGalCer-C26:0 and
continued to accumulate throughout the 8 hr chase (Figure 3C), whereas with αGalCer-C20:2
or -C10:0, the complexes formed rapidly and began declining immediately during the chase
period. Experiments using responses of iNKT cells to analyze the kinetics of cell-surface
appearance gave analogous results (Figure S5). Thus, although our findings did not provide
evidence for presentation by different APC types as a major factor accounting for the altered
cytokine responses to different analogs of αGalCer, they revealed a consistent tendency for
glycolipids that induced Th2 cell-type biased cytokine responses to be presented with more
rapid kinetics compared to αGalCer analogs that induced mixed Th1 and Th2 cell-type cytokine
responses.
Direct Imaging of CD1d Loading with αGalCer Analogs
To visualize the kinetics and sites of mCD1d loading by αGalCer analogs in live cells, we
analyzed intact JAWS II cells for surface staining with mAb L363 after 1, 4, or 16 hr of
incubation with αGalCer-C26:0 or with either of two Th2 cell-type cytokine-biasing analogs
(αGalCer-C20:2 or -C10:0) (Figure 4A). Strong staining of the plasma membrane was seen
after 16 hr of incubation in all cases. However, only αGalCer-C20:2 or -C10:0 showed L363
staining at earlier time points, consistent with the rapid kinetics of loading observed by flow
cytometry. To image earlier steps in glycolipid loading, we permeabilized and fixed cells prior
to staining with L363 and with an antibody to the late endosomal and lysosomal marker
LAMP-1 (Figure 4A). After incubation for 1 hr with glycolipids, L363 staining was observed
at the plasma membrane for αGalCer-C20:2 and -C10:0, and no colocalization with LAMP-1
was present. Colocalization with LAMP-1 was observed for mCD1d complexes formed with
these analogs only at the latest time point studied (16 hr), suggesting that they arrived at late
endocytic compartments via recycling from the plasma membrane. In contrast, L363 staining
of cells pulsed for 1 hr with αGalCer-26:0 was observed only in a punctate intracellular
distribution that was completely distinct from LAMP-1 staining, indicating that the initial
association with mCD1d occurred in an endocytic compartment separate from typical late
endosomes and lysosomes. At 4 hr, these complexes began to colocalize with LAMP-1, and
only at 16 hr could clear surface staining be seen along with the persistent intracellular staining
in LAMP-1+ compartments (Figure 4A).
The lack of detectable intracellular mCD1d loading prior to cell-surface mCD1d-αGalCer
complex accumulation with Th2 cell-type cytokine-biasing analogs suggested a reduced
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requirement for endosomal loading as a general property of such glycolipids. This was
confirmed with a functional assay to compare presentation of each analog by APCs expressing
either wild-type mCD1d (mCD1d.WT) or a cytoplasmic tail deletion mutant (mCD1d.TD)
deficient in endosomal trafficking and localization (Jayawardena-Wolf et al., 2001)
(Figure 4B). With A20 B lymphoma cells expressing mCD1d.WT, αGalCer-C26:0 and -C24:0
were significantly more potent at activating iNKT cells compared to all Th2 cell-type cytokine-
biasing analogs. In contrast, the opposite was observed with A20 cells expressing mCD1d.TD.
This inversion of relative potencies was consistent with a requirement for endosomal loading
of mCD1d by αGalCer-C26:0 and -C24:0 and with a general lack of this requirement for
analogs that preferentially induced Th2 cell-type cytokine responses.
Requirement for Lipid Transfer Factors
The efficient loading of CD1 molecules with lipids such as αGalCer-C26:0 is known to involve
cofactors that enhance the transfer of lipids from micelles or membranes into the antigen-
binding groove of the CD1 protein. The best known of these cofactors are resident intracellular
lipid binding and transfer proteins including those belonging to the saposin family, GM2
activator proteins, and Niemann-Pick type C1 and C2 proteins (Zhou et al., 2004; Sagiv et al.,
2006; Yuan et al., 2007; Schrantz et al., 2007). Most of these are known to have detergent-like
activities that facilitate solubilization of lipids and their exchange between hydrophobic
binding sites. In an in vitro model for this activity of endosomal lipid transfer proteins, we
investigated the impact of detergent (0.05% Triton X-100) on the loading of αGalCer analogs
onto purified mCD1d or hCD1d tetramers (Figures 5A and 5B). With mCD1d, there was a
clear enhancing effect of Triton X-100 on the formation of tetramers that bound to iNKT cell
TCRs when αGalCer-C26:0 or -C24:0 were used as ligands, whereas loading of all six Th2
cell-type cytokine-biasing analogs was optimal in the absence of detergent (Figure 5A).
Largely similar findings were obtained with hCD1d tetramers (OCH failed to form hCD1d
tetramers with iNKT cell-binding avidity under any conditions) (Figure 5B). Overall, this
consistent lack of detergent dependence for loading of CD1d by all Th2 cell-type cytokine-
biasing analogs was a further unifying feature of such compounds and pointed to differences
in aqueous solubility of αGalCer analogs as an important determinant of their effects on iNKT
cell activation.
To extend these observations to a more physiological model, we tested the effects of purified
recombinant saposin A, B, C, and D proteins on loading of αGalCer analogs. In an in vitro
loading system with recombinant mCD1d and a functional readout with iNKT cell hybridoma
responses, we found that loading of αGalCer-C26:0 was dependent either on the presence of
detergent (0.1% Triton X-100) or on the presence of a purified saposin (Figure 5C). Saposin
B was strongly active in this regard, with minimal or no activity for saposins A, C, or D. This
enhancing effect of saposin B was observed at neutral pH and remained strong and specific
under acidic conditions approximating the endosomal environment in which saposins normally
function. In marked contrast, all four saposins showed only modest enhancement of loading
with αGalCer-C10:0 at neutral pH and actually reduced mCD1d loading at acidic pH.
Lipid Raft Localization of αGalCer-CD1d Complexes
Recent studies highlight the localization of a fraction of CD1d proteins to detergent insoluble
plasma membrane microdomains (i.e., lipid rafts) and suggest that this may have functional
relevance for iNKT cell activation (Lang et al., 2004; Park et al., 2005; Peng et al., 2007). We
assessed the potential involvement of lipid rafts in controlling the cytokine bias of iNKT cell
activation by comparing the extent of raft colocalization of mCD1d complexes forming in
APCs pulsed with αGalCer-C26:0 versus -C10:0 (Figure 6A). Consistent with the findings of
Peng et al., a relatively small fraction of total surface mCD1d expressed by JAWS II cells
colocalized with lipid rafts, which were identified by the binding of cholera toxin B subunit
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(CTxB) to the GM1 gangliosides enriched in these microdomains (Kenworthy et al., 2000). In
contrast, imaging of mAb L363 binding to cells that had been incubated with αGalCer-C26:0
showed strong colocalization with CTxB staining, indicating localization predominantly in
lipid rafts. This was not observed for L363 staining of cells incubated with αGalCer-C10:0;
this staining showed extremely limited colocalization with CTxB staining indicating exclusion
from GM1-enriched lipid rafts (Figures 6A and 6B).
Another property of lipid rafts is their resistance to solubilization by nonionic detergents due
to their enrichment in cholesterol, sphingomyelin, and saturated acyl chains (Pike, 2008). To
assess the localization of αGalCer-mCD1d complexes in detergent insoluble microdomains,
we used a flow-cytometry-based assay that quantitates the resistance of lipid-raft-associated
transmembrane proteins to extraction by low concentrations of Triton X-100 (Gombos et al.,
2004a; Peng et al., 2007). Using this approach (Figure 6C), we observed that a substantial
fraction (∼70%) of total surface mCD1d (identified with mAb K253) could be extracted from
the cell surface within 90 s by 0.1% Triton X-100, consistent with a major nonraft localizing
cohort of mCD1d. Similarly, the majority of L363 staining resulting from preincubation of the
cells with αGalCer-C10:0 was eliminated by a brief exposure to 0.1% Triton X-100, indicating
that mCD1d complexes containing this glycolipid were mainly localized to detergent soluble
nonraft domains of the plasma membrane. Complexes formed with αGalCer-C20:2 also
showed significant extraction by detergent in these experiments, although less complete than
for αGalCer-C10:0. In striking contrast, complexes of mCD1d containing αGalCer-C26:0 were
extremely resistant to detergent extraction (∼90% remaining after 90 s).
These results strongly indicated that αGalCer analogs differ profoundly with respect to
presentation by lipid-raft-associated or nonraft-associated mCD1d molecules, and such a
difference can be envisioned to have major effects on the strength and quality of iNKT cell
activation (Park et al., 2005). To assess functional consequences of raft localization of CD1d-
glycolipid complexes, we analyzed the effects of methyl-β-cyclodextrin (MβCD) treatment on
the iNKT cell stimulatory capacity of CD1d-glycolipid complexes in vitro and in vivo
(Figure 7). MβCD substantially disrupts lipid raft microdomain structures by extracting
cholesterol from the outer leaflet of the plasma membrane and reduces the raft association of
plasma membrane CD1d molecules (Park et al., 2005). Treatment of DCs pulsed with αGalCer-
C26:0 with MβCD markedly reduced their ability to stimulate IFN-γ production by splenocytes
and had no effect on stimulation of IL-4. This effect was not observed for in vitro stimulations
with αGalCer-C20:2- or αGalCer-C10:0-pulsed DCs, which were unaffected by MβCD
(Figure 7A). A similar result was obtained for in vivo iNKT cell stimulation after injection of
MβCD-treated DCs (Figure 7B). These results implied that cholesterol-rich plasma membrane
lipid rafts were highly relevant for the mixed cytokine response to αGalCer-C26:0 but were
dispensable for iNKT cell responses to Th2 cell-type cytokine-biasing agonists, consistent with
their lack of presentation by lipid-raft-associated CD1d molecules.
Discussion
Structurally modified forms of αGalCer have been explored in recent years as a strategy for
more selectively activating specific functions of iNKT cells to exploit their therapeutic
potential (Miyamoto et al., 2001; Schmieg et al., 2003; Miyake and Yamamura, 2005; Yu et al.,
2005; Forestier et al., 2007). The current study addresses the fundamental mechanisms that
cause certain structural analogs of αGalCer to activate the strong, preferential production of
Th2 cell-type cytokines by iNKT cells that is associated with anti-inflammatory or tolerizing
effects. Our studies extend other work centered mainly on the truncated sphingosine analog
known as OCH, which emphasized the extremely low affinity or avidity of this ligand for iNKT
cell TCRs (Oki et al., 2004). The weak binding of OCH-loaded CD1d molecules to the iNKT
cell TCR, confirmed in the current study, suggested that an affinity threshold model could
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account for the Th2 cell-type cytokine bias and overall anti-inflammatory effects that are
observed after activation of iNKT cells with this αGalCer variant (McCarthy et al., 2007).
However, our findings argue against an affinity threshold model as the principle mechanism
accounting for the properties of many or most Th2 cell-type cytokine-biasing iNKT cell
agonists. As demonstrated in an earlier study (Forestier et al., 2007) and extended here, these
analogs showed a remarkable range of avidities for mouse or human iNKT cell TCRs.
Structural studies of CD1d-glycolipid complexes also suggest that altered functional outcomes
of iNKT cells to N-acyl variants are unlikely to be due purely to direct effects on TCR affinity
(Zajonc et al., 2005; Koch et al., 2005; Borg et al., 2007). These studies reinforce the view that
alterations in the sphingoid base or acyl chain of αGalCer are mostly hidden from the TCR
contact surface by their positioning within the A' and F' pockets of the CD1d lipid-binding
groove. Although modeling suggests that a structural rearrangement of the TCR contact surface
may be a result of incomplete filling of the A' pocket by the truncated sphingoid base of OCH
(McCarthy et al., 2007), the high avidity of at least some Th2 cell-type biasing N-acyl variants
of αGalCer for iNKT cell TCRs argues against such effects as a universal explanation for the
altered cytokine responses. Thus, mechanisms other than or in addition to variations in
signaling based simply on TCR affinity must underlie the altered cytokine responses stimulated
by certain αGalCer analogs.
An alternate mechanism supported by our data relates to how these compounds become
associated with CD1d in APCs. Our findings did not strongly support the previously proposed
hypothesis that presentation by different APC types accounts for qualitative differences in
iNKT cell responses (Bezbradica et al., 2005; Im et al., 2006). Instead, what emerged strongly
from our studies was a consistent tendency for Th2 cell-type-biasing glycolipids to be presented
with rapid kinetics and without a requirement for intracellular loading of CD1d, apparently as
a result of their ability to rapidly associate with CD1d molecules directly at the cell surface.
This was in marked contrast to αGalCer-C26:0, which underwent intracellular loading and was
presented more slowly. It is noteworthy that a similar finding has been reported recently for
αGalCer-C20:2 in studies that used novel phage display-derived antibodies with TCR-like
specificity against the hCD1d/αGalCer complexes (Denkberg et al., 2008), suggesting the
potential relevance of our observations to human iNKT cell responses.
The lack of a requirement for detergent or for a lipid transfer protein (e.g., saposin B) as an
accessory factor for glycolipid loading was also consistently observed for Th2 cell-type-biasing
glycolipids, and we speculate that this was related directly to their ability to rapidly load
surface-expressed CD1d molecules. The chemical structures of αGalCer analogs with
pronounced Th2 cell-type cytokine-biasing effects are variable, but all of these are
characterized by substantial shortening of their aliphatic chains or the inclusion of polar
substitutions such as double bonds or oxygen atoms. These modifications increase the overall
polarity and reduce the hydrophobicity of these glycolipids relative to compounds giving mixed
cytokine responses like αGalCer-C26:0 and -C24:0, or the even more hydrophobic Th1 cell-
type cytokine-biasing C-glycoside variant of αGalCer-C26:0 (Schmieg et al., 2003; Fujii et al.,
2006).
Our demonstration that αGalCer analogs can differ markedly with regard to the extent to which
they are presented by lipid-raft-associated CD1d molecules provides an attractive mechanism
to explain the stimulation of biased cytokine responses by particular glycolipids. It is likely
that the forced intracellular loading of a compound such as αGalCer-C26:0 leads to the
organized transport of glycolipid-CD1d complexes into cholesterol-rich lipid rafts, which also
are known to facilitate recruitment into immunological synapses along with a variety of other
molecules involved in T cell activation (Gombos et al., 2004b). Conversely, direct loading of
CD1d molecules on the surface of the cell results in exclusion from such lipid rafts and therefore
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promotes a very different type of iNKT cell activation. Such lipid-raft-dependent alternative
activation, although novel for iNKT cells and CD1d-dependent antigen recognition, has
previously been described in studies of MHC class II presentation that have remarkable
parallels with our observations on CD1d. For example, it has been shown that a substantial
fraction of plasma membrane MHC class II molecules are concentrated in cholesterol-rich lipid
rafts and tetraspannin microdomains (Poloso and Roche, 2004). Analogous to our findings
with CD1d-presented glycolipids, peptide antigens loaded onto MHC class II molecules in
intracellular compartments are presented preferentially in rafts and favor the stimulation of
Th1 cell-type responses by conventional CD4+ T cells. In contrast, peptides loaded
exogenously at the cell surface are presented mainly by molecules outside of rafts and show a
tendency to stimulate Th2 cell-type responses (Buatois et al., 2003).
Although our experiments used synthetic lipid agonists to show how ligand structure may
regulate the quality of iNKT cell responses, the results may provide insight into how natural
endogenous and foreign lipid ligands are presented and sensed by the CD1d-iNKT cell axis.
Thus, the preferential loading of glycolipid antigens with relatively short or polyunsaturated
alkyl tails onto cell-surface CD1d proteins may represent a constitutive process of normal self
-recognition that biases the immune system toward tolerance or Th2 cell-type cytokine
responses in the absence of an infectious agent. Interestingly, other recent data indicate that
glycolipids with this type of structure are not only more efficient at loading directly onto surface
CD1d but are also actively excluded from forming stable complexes with endosomal CD1d at
low pH (A. Bendelac, personal communication). Such findings are mirrored by our observation
that recombinant saposins have the ability to unload αGalCer-C10:0 from CD1d at pH 5.0, but
not at neutral pH. Taken together, these studies are evidence for a finely tuned antigen-
presenting system in which the sorting of structurally divergent glycolipids onto different
cohorts of CD1d molecules is a key mechanism for regulating the balance between tolerogenic
and proinflammatory functions of iNKT cells.
Experimental Procedures
Mice, Cell Lines, and Reagents
Female C57BL/6 and BALB/c mice were purchased from the Jackson Laboratory and housed
under specific pathogen-free conditions. All procedures were approved by the Institutional
Animal Use Committee. Murine iNKT hybridomas DN3A4-1.2 (Vα14Vβ8.2) and DN3A4-1.4
(Vα14Vβ10) and A20 B lymphoma cells transfected with wild-type or tail-deleted mouse
CD1d proteins were provided by M. Kronenberg (La Jolla Institute for Allergy and
Immunology, San Diego, CA, USA). Murine iNKT hybridomas N38.2H4 (Vα14Vβ7) and
DN32.D3 (Vα14Vβ8.2) were provided by K. Hayakawa (Fox Chase Cancer Center,
Philadelphia, PA, USA) and A. Bendelac (University of Chicago), respectively. The C57BL/
6.Trp53−/−-derived dendritic cell line JAWS II was from the American Type Culture
Collection. Murine cells were cultured in RPMI-1640 with 10% fetal calf serum, 100 mM
HEPES, and 50 μM 2-mercaptoethanol (complete medium). Human iNKT cell clones and
monocyte-derived DCs were produced and cultivated as described (Exley et al., 1997).
Monoclonal antibodies specific for mouse CD3ɛ (clone 145-2C11, APC-conjugated), NK1.1
(PK136, APC), CD11c (HL3, APC), and F4/80 (BM8, FITC) were purchased from BD
Biosciences. Anti-mouse CD19 (clone 6D5, SPRD) was purchased from Southern Biotech.
Monoclonal antibodies to human CD3 (OKT3, FITC) and to human iNKT invariant TCRα
chain CDR3 region (6B11, PE) were from BD Biosciences. Anti-LAMP-1 monoclonal
antibody (clone 1D4B, Alexa Fluor 488) was from Santa Cruz Biotechnology. The mCD1d-
αGalCer complex-specific mAb L363 and mCD1d-specific mAb K253 were produced in our
laboratory (Yu et al., 2007). Monoclonal antibody pairs specific for human and mouse
cytokines were used in capture ELISAs as previously described (Im et al., 2006; Forestier et al.,
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2007). Glycolipids used in this study were synthesized and solubilized for in vivo injection or
addition to cell culture media as described (Ndonye et al., 2005; Yu et al., 2005; Forestier et al.,
2007).
In Vitro and In Vivo Activation of iNKT Cells
For in vitro stimulation, murine iNKT hybridomas at 5 × 104 cells/well in 96-well plates were
stimulated with an equal number of either JAWS II cells or transfected A20 cells in complete
medium with glycolipids for 12 hr at 37°C, and levels of murine IL-2 secretion were
determined. For some experiments, APCs were preincubated with glycolipids for 12 hr or fixed
with paraformaldehyde (1% for 2 min at RT) prior to the addition of iNKT cell hybridomas.
For in vitro stimulation of murine splenic iNKT cells, splenocytes from BALB/c or C57BL/6
mice were plated at 5 × 105 cells per well in complete medium in 96-well plates and stimulated
with glycolipids for 48 hr at 37°C. Subsequently the levels of IL-4, IL-13, and IFN-γ in culture
supernatants were quantified by capture ELISA. For assays with methyl-β-cyclodextrin
(MβCD) treatment of APCs, we prepared splenic DCs with a CD11c+ cell isolation kit from
Miltenyi Biotech from mice that had been injected s.c. 14 days previously with 105 Flt3-ligand-
secreting B16 melanoma cells to increase the yield (Mach et al., 2000). Purified CD11c+ cells
were cultured in complete medium for 18 hr with glycolipids (100 nM) as indicated, washed,
and incubated at 37°C for 15 min in medium with or without 10 mM MβCD (Sigma-Aldrich)
and subsequently fixed (1% paraformaldehyde) and cultured in 96-well plates at 2 × 105 cells/
well with autologous splenocytes (4 × 105 cells per well). Supernatants were harvested 24 hr
later for measurement of cytokines. In vivo activation of iNKT cells by i.p. glycolipid injection
(4 nmoles) of female C57BL/6 mice and measurement of serum cytokines was done as
previously described (Forestier et al., 2007). For determination of MβCD effects on in vivo
presentation, CD11c+ purified splenic DCs from C57BL/6 mice injected s.c. 14 days previously
with 105 Flt3-ligand-secreting B16 melanoma cells were cultured in complete medium with
100 nM of glycolipids for 18 hr, washed, and incubated for 15 min in RPMI-1640 with or
without 10 mM MβCD. After extensive washing, the cells were injected i.p. into naive C57BL/
6 mice (106 cells/mouse), and blood was collected at 2 hr and 24 hr for analysis of serum
cytokine levels.
CD1d Tetramer Assembly and Flow Cytometry
Recombinant CD1d proteins were produced and assembled into tetramers for staining as
previously described (Forestier et al., 2007). To obtain optimally loaded tetramers for iNKT
cell staining, we loaded mCD1d with αGalCer-C26:0 and -C24:0 in the presence of 0.05%
Triton X-100 (Sigma-Aldrich) and loaded mCD1d with other glycolipids without Triton
X-100. For loading of hCD1d, 0.05% Triton X-100 was included with αGalCer-C26:0, -C24:0,
and -C20:4, whereas other glycolipids were loaded without Triton X-100. For surface staining
of αGalCer/mCD1d complexes, murine splenocytes or JAWS II cells were incubated with 250
nM glycolipids for various times and then 0.2 μg/ml mAb L363 (Alexa Fluor 647 or biotin
conjugated) was added directly to the culture for an additional 30 min at RT. In some
experiments, additional fluorochrome-conjugated antibodies specific for leukocyte
subpopulations were added for the last 15 min of incubation. All samples were analyzed with
the FACSCalibur flow cytometer (BD Biosciences).
In Vitro CD1d Loading Assay
Recombinant murine CD1d proteins at 4 μg/ml in 50 μl PBS were coated on the surfaces of
microtiter plate wells for 2 hr at 37°C and then washed with PBS for removal of unbound
proteins. Subsequently, various concentrations of glycolipids in 0.1 M sodium phosphate buffer
(pH 7.0) or 0.1 M sodium citrate buffer (pH 5.0) containing 150 mM NaCl were incubated
with or without 0.05% Triton X-100 or recombinant purified human saposins A, B, C, or D at
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10 μg/ml for another 2 hr at 37°C. Saposins were produced and purified as described (Yuan
et al., 2007). After extensive washing with PBS and media, 5 × 104 murine iNKT hybridoma
DN32.D3 cells were added in 200 μl of complete medium and incubated at 37°C for 14 hr.
Supernatants were analyzed for murine IL-2 by capture ELISA.
Confocal Microscopy and Lipid Raft Analysis
JAWS II cells were incubated at 37°C with 100 nM glycolipids for various times as indicated.
For surface staining, live cells were harvested and washed extensively with PBS, resuspended
in PBS + 1% BSA + 0.1% NaN3, stained on ice with 10 μg/ml Alexa Fluor 647-conjugated
mAb L363 for 30 min, and lastly washed extensively and fixed with 4% paraformaldehyde.
Cells were washed with PBS and settled onto poly-L-lysine-coated coverslips for 30 min and
mounted with ProLong Gold with DAPI mounting medium (Invitrogen). For intracellular
staining, JAWS II cells grown on glass coverslips were fixed in 4% paraformaldehyde,
permeabilized with 0.05% Triton X-100 for 5 min, and stained with 10 μg/ml Alexa Fluor 647-
conjugated L363 and FITC-conjugated anti-LAMP-1. Coverslips were washed and mounted.
Confocal images were obtained with a Leica SP2 AOBS confocal microscope (Leica
Microsystems). For colocalization of αGalCer/mCD1d complexes with ganglioside GM1-
enriched plasma membrane lipid rafts, JAWS II cells were incubated for 18 hr at 37°C in
complete medium without or with 100 nM of glycolipids. Cells were then washed with PBS,
resuspended in PBS + 1% BSA + 0.1% NaN3, and stained on ice with the 10 μg/ml of Alexa
Fluor 647-conjugated mAb L363 or mAb K253 plus cholera toxin B subunit (Invitrogen) for
30 min. After washing once with PBS, cells were incubated with Texas Red-conjugated rabbit
anti-cholera toxin B, fixed, and mounted for confocal microscopy. We performed quantitative
analysis of colocalization by selecting 20–25 random cells in each group and determining a
Pearson correlation coefficient for the distribution of pixel densities for K253 or L363
fluorescence compared to cholera toxin B-specific fluorescence. Assessment of mCD1d or
αGalCer/mCD1d complex association with detergent resistant membrane microdomains by
flow cytometry was carried out with accordance to a published protocol (Gombos et al.,
2004a). JAWS II cells were incubated in complete medium with or without indicated
glycolipids for 18 hr, harvested, washed, and resuspended in PBS with 1% FCS. After staining
with Alexa Flour 647 conjugates of mAbs K253 or L363, cells were resuspended at 106/ml in
PBS with 1% FCS and analyzed for fluorescence with the kinetic mode for acquisition with
time as a variable with Cell Quest software and the FACSCalibur (BD Biosciences). After
recording baseline fluorescence for 15 s, Triton X-100 was added to a final concentration of
0.1% with brief (∼1 s) vortexing to mix, and acquisition of fluorescence level in kinetic mode
was continued for another 60 s.
Supplemental Data
Refer to Web version on PubMed Central for supplementary material.
Supplemental Data
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Synthetic Analogs of αGalCer
(A) Structures and nomenclature of iNKT cell-activating αGalCer analogs used in this study.
The nomenclature used in most cases is based on the identity of the amide-linked acyl group
in the ceramide moiety. Acyl carbon chain length and number of unsaturations are indicated
by the names of most analogs, with exceptions being OCH (which has a C24 saturated acyl
chain) and the compounds with amide-linked prostaglandin B1 (PGB1) or 4-fluorophenyl
acetate (4FPA) groups. The phytosphingosine base is 18 carbons in length for all analogs except
OCH, which has a nine-carbon base.
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(B) Hybridoma DN3A4.1-2 (Vβ8.2+) was stimulated with each of the αGalCer analogs at a
range of concentrations with JAWS II cells as APCs, and the amounts of IL-2 production were
analyzed. Potencies of glycolipids are shown as 1/EC50 (as defined in Figure S1). The graph
shows mean values ± SD, and the results shown are representative of three independent
experiments.
(C) Ratios of IL-4 to IFN-γ (x axis) plotted against the ratios of IL-13 to IFN-γ (y axis) for
culture supernatants of BALB/c splenocytes stimulated with glycolipids for 48 hr. Ratios for
the C26:0 and C24:0 analogs are shown for stimulation with a range of glycolipid
concentrations (3, 10, and 30 nM). Other analogs are shown at one concentration (3 nM) for
clarity, although similar trends were observed at higher glycolipid concentrations (Figure S2).
Data are representative of three experiments.
(D) C57BL/6 mice (four mice per group) received a single injection i.p. of four nanomoles of
each glycolipid, and blood samples were obtained at 2, 8, and 23 hr. Concentrations of IFN-
γ, IL-4, and IL-12p70 were determined in serum by capture ELISA. “ND” stands for not
detected. The graphs show mean ± SD for triplicate values, and results shown were
representative of two independent experiments.
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Figure 2.
Characterization of iNKT Cell TCR Interactions with αGalCer Analogs
(A) Flow cytometry analysis of human and murine iNKT cells with αGalCer analog-CD1d
tetramers. In the top row, murine iNKT cells from C57BL/6 splenocytes were costained with
αGalCer analog-loaded or unloaded mCD1d tetramers conjugated with PE (x axis) and
αGalCer-C26:0-loaded-mCD1d tetramers conjugated with APC (y axis). In the bottom row,
human PBMCs were similarly costained with human glycolipid-loaded CD1d tetramers.
(B) Binding avidity of glycolipid-mCD1d complexes to murine iNKT cell TCRs. Histograms
at left show tetramer staining of NK1.1+ CD3+ T cells in C57BL/6 splenocytes with glycolipid-
loaded tetramers at 20 nM. Mean fluorescence intensity (MFI) for staining of this population
with tetramers at various concentrations is plotted (center), and the equilibrium dissociation
constants (KD) were determined as the concentrations of glycolipid-mCD1d complexes
required to yield 50% of maximal binding. Values are plotted as 1/KD, which is directly
proportional to TCR avidity (right).
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(C) Similar experiments as in (B) for binding of αGalCer-hCD1d tetramers to a human iNKT
cell clone (CD4+ clone HDD11). All results shown were representative of two independent
experiments.
Im et al. Page 17
Published as: Immunity. 2009 June 19; 30(6): 888–898.
Sponsored D
ocum
ent 
 Sponsored D
ocum
ent 
 Sponsored D
ocum
ent
Figure 3.
Direct Analysis of Presentation of αGalCer Analogs with Complex-Specific mAb Staining
(A) Mouse splenocytes cultured with either vehicle only (0.02% DMSO) or with the indicated
αGalCer analogs (100 nM) were harvested after 1 hr or 19 hr of incubation and stained with
mAb L363 or anti-CD1d mAb 1B1 and with mAbs specific for CD11c, CD19, and F4/80
(Figure S4). Filled histograms show L363 staining of cells cultured with vehicle only, and open
histograms show cells cultured with indicated glycolipids. At the left, the total CD1d staining
with mAb 1B1 (open histograms) compared to isotype control mAb (filled histograms) are
shown on cells cultured for 19 hr with DMSO only.
(B) JAWS II cells were incubated with glycolipids (250 nM) for various times ranging from
0.5–18 hr as indicated, stained with mAb L363, and analyzed by flow cytometry. Dashed line
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histograms show L363 staining of cells incubated with medium only, and bold histograms
show L363 staining of cells incubated with αGalCer analogs.
(C) JAWS II cells were pulsed with indicated αGalCer analogs (500 nM) for 1.5 hr, washed
extensively, and recultured at 37°C for various chase times. Upon harvesting, cells were placed
on ice and subsequently stained with mAb L363 for flow cytometry analysis. Histogram
overlays show L363 staining of cells pulsed initially with vehicle only (DMSO, dashed
histograms) or with αGalCer analog (bold histograms). The graph on the right shows MFI of
L363 staining at each chase time represented as percent of the maximum value measured during
the course of the experiment. All results shown (A, B, and C) were representative of at least
two independent experiments.
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Figure 4.
Cell Surface versus Intracellular Loading of mCD1d with Different αGalCer Analogs
(A) On the left, surface accumulation of CD1d-αGalCer complexes was studied with JAWS
II cells harvested after incubation with the indicated glycolipids for 1, 4, or 16 hr and then
stained without permeabilization with mAb L363 (red). Cells were then fixed, stained with
DAPI for nuclei visualization (blue), and analyzed by confocal microscopy. On the right, the
intracellular formation and trafficking of CD1d-αGalCer complexes were analyzed by
treatment of JAWS II cells with αGalCer analogs for 1, 4, and 16 hr followed by fixation and
permeabilization. The cells were stained for CD1d-αGalCer complexes (L363, red), late
endosomes and lysosomes (anti-LAMP-1, green), and nuclei (DAPI, blue). Results are
representative of three separate experiments. The scale bar represents 10 μm.
(B) Murine iNKT cell hybridoma cells (DN3A4.1-2) were stimulated with αGalCer analogs.
As APCs for these stimulations, we used A20 cells transfected with wild-type CD1d
(CD1d.WT) or cytoplasmic-tail-deleted CD1d (CD1d.TD). Supernatant concentrations of IL-2
release were determined after 12 hr. IL-2 production over a range of concentrations is shown
for αGalCer-C26:0 and two analogs that produce a Th2 cell-type cytokine bias (αGalCer-C20:2
and -PGB1). The bar graph on the right shows relative potencies [(EC50 with presentation by
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CD1d.WT)/(EC50 with presentation by CD1d.TD)] of each glycolipid presented by CD1d.TD
versus CD1d.WT.
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Figure 5.
Lack of Detergent-like Cofactor Dependence of Th2 Cell-Type Cytokine-Biasing αGalCer
Analogs
(A) Glycolipids were incubated for 24 hr at 37°C with murine CD1d proteins in the absence
(top row) or presence (bottom row) of 0.05% Triton X-100. The resulting complexes were
assembled as tetramers and used for staining mouse iNKT hybridoma DN3A4.1-2. The dashed
line histograms show background staining with unloaded tetramers, and the bold histograms
show staining with glycolipid loaded tetramers.
(B) The same analysis as in (A) except with human CD1d tetramers, which were also used for
DN3A4.1-2 staining.
(C) Glycolipids at various concentrations were incubated with immobilized mCD1d protein
for 2 hr in pH 7.0 or pH 5.0 buffers with no additives (medium) or in the same buffers containing
the indicated purified recombinant saposins (10 μg/ml) or Triton X-100 (0.05%). After
washing, DN32.D3 iNKT hybridoma cells were added and supernatant concentrations of IL-2
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were determined after an additional 14 hr of incubation. All results shown (A, B, and C) were
representative of at least two independent experiments.
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Figure 6.
Plasma Membrane Lipid Raft Association of CD1d-αGalCer Complexes
(A) Top row shows steady state localization of total cell-surface mCD1d on JAWS II cells
(anti-mCD1d mAb K253 (green), and cholera toxin B subunit (CTxB) followed by clustering
with anti-CTxB antiserum (red). Areas of overlap in the merged image are shown in the black-
and-white image on the right (region of overlap). In the two lower rows, JAWS II cells were
incubated for 18 hr with the indicated glycolipids and then stained with CD1d-αGalCer
complex-specific mAb L363 (green) and CTxB (red). Merged and region of overlap images
show marked colocalization of mCD1d-αGalCer-C26:0 with GM1-enriched lipid rafts, as
opposed to minimal overlap for mCD1d-αGalCer-C10:0 complexes. The scale bar represents
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10 μm. Results shown for individual cells were typical of >20 cells analyzed for each parameter
with or without incubation with the indicated glycolipids.
(B) Quantitation of colocalization shown in (A) for multiple randomly selected individual cells.
Pearson correlation coefficient for the distribution of pixel densities for K253 or L363
fluorescence compared to cholera toxin B-specific fluorescence are plotted for each individual
cell analyzed. Values for p were determined by one-way ANOVA.
(C) Flow cytometry assay for αGalCer-mCD1d complex association with detergent-resistant
membrane microdomains. JAWS II cells were incubated with or without the indicated
glycolipids for 18 hr and stained with mAbs K253 or L363. Baseline fluorescence levels were
recorded for 15 s, after which Triton X-100 was added to 0.1% (arrow) and recording was
resumed for another ∼60 s. Each symbol indicates mean fluorescence intensity (MFI) averaged
over 1 s of recording. MFI values were normalized to the mean baseline levels for each sample
during the initial 15 s of recording. Results are representative of three experiments.
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Figure 7.
Functional Consequences of Membrane Lipid Raft Association of Glycolipid-Loaded CD1d
Molecules
(A) C57BL/6 BMDCs were pulsed for 18 hr with the indicated glycolipids, washed, and
incubated for 15 min in medium alone (hatched bars) or medium containing 10 mM MβCD
(solid bars). Cells were then fixed (1% paraformaldehyde) and used for stimulating autologous
splenocytes for 24 hr, after which supernatant concentrations of IFN-γ and IL-4 were measured.
Dotted lines indicate the background levels of cytokines in cultures with BMDC pulsed with
vehicle only. Means and standard deviations for triplicate cultures are shown, and results are
representative of three experiments. ∗∗p < 0.01 (ANOVA, Bonferroni post-test).
(B) Effect of MβCD on in vivo presentation of αGalCer analogs. Splenic DCs were pulsed ex
vivo with the indicated glycolipids for 18 hr and then incubated for 15 min in medium without
(−, hatched bars) or with 10 mM MβCD (+, solid bars). After extensive washing, the cells were
injected i.p. into naive C57BL/6 mice (106 cells/mouse). Serum was assayed for IL-4 at 2 hr
and for IFN-γ at 24 hr postinjection. Data shown are means and standard deviations for pooled
data from two experiments that had three mice per group. ∗∗p < 0.01 (ANOVA, Bonferroni
post-test); NS, not significant (p > 0.05).
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